Trial Profile
ZOSYN 2.25 for Intravenous Injection, ZOSYN 4.5 for Intravenous Injection and ZOSYN 4.5 for I.V. Infusion Bag (Special drug use-results survey of ZOSYN in malignant tumor except the blood-forming organ malignant tumor patients with febrile neutropenia)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2017
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Febrile neutropenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 15 Jun 2016 New trial record